Combining HbA1c and glycated albumin improves detection of dysglycaemia in mixed-ancestry South Africans

被引:5
|
作者
Kengne, Andre Pascal [1 ,2 ]
Matsha, Tandi E. [3 ]
Sacks, David B. [4 ]
Zemlin, Annalise E. [5 ]
Erasmus, Rajiv T. [5 ]
Sumner, Anne E. [6 ,7 ]
机构
[1] South African Med Res Council, Noncommunicable Dis Res Unit, POB 19070,Tygerberg, ZA-7505 Cape Town, South Africa
[2] Univ Cape Town, Dept Med, Cape Town, South Africa
[3] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Cardiometab Hlth Res Unit, SAMRC,CPUT, Cape Town, South Africa
[4] Natl Inst Hlth Clin Ctr, Bethesda, MD USA
[5] Univ Stellenbosch, Fac Med & Hlth Sci, Natl Hlth Lab Serv NHLS, Div Chem Pathol, Cape Town, South Africa
[6] Natl Inst Diabet & Digest & Kidney Dis, Natl Inst Hlth, Diabet,Endocrinol & Obes Branch, Sect Ethn & Hlth, Bethesda, MD USA
[7] Natl Inst Minor Hlth & Hlth Dispar, NIH, Bethesda, MD USA
基金
英国医学研究理事会;
关键词
Dysglycaemia; HbA1c; Glycated albumin; Screening; Africa; ABNORMAL GLUCOSE-TOLERANCE; DIABETES-MELLITUS; HEMOGLOBIN A(1C); DIAGNOSIS; CLASSIFICATION; PREVALENCE; MANAGEMENT; A1C;
D O I
10.1016/j.eclinm.2022.101443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Combining HbA(1c) with glycated albumin (GA) may improve detection of dysglycaemia. As BMI correlates positively with HbA1c and negatively with GA, HbA(1c) may be more effective in obese and GA in nonobese individuals. Methods To relate these findings to Africans, we assessed in 1274 South Africans living in CapeTown (male 26%; age 4816y; BMI 28.7 kg/m(2) (range 15.6-73.8); obesity 39.9% and no prior diabetes history) the: (1) correlation of BMI with HbA1c and GA, (2) ability of HbA(1c) and GA separately and jointly, to detect OGTT-diagnosed dysglycaemia (diabetes plus prediabetes). Data collection took place between 2014 and 2016 in the City of Cape Town. Dysglycaemia was diagnosed by glucose criteria for the OGTT. Youden index was used to optimize diagnostic thresholds for HbA1c and GA. Findings Normal glucose tolerance, prediabetes and diabetes occurred in 76%, 17% and 7%, respectively. BMI positively correlated with HbA(1c )[r = 0.34 [95%CI: 0.29,0.39)] and negatively with GA [-0.08 (0.13,0.03)]. For HbA(1c )the optimal threshold by Youden-index for dysglycaemia diagnosis was: 6.0% (95%CI: 5.8,6.2) and for GA: 13.44% (12.72,14.71). In the nonobese, obese and total cohort, HbA(1c)-alone detected: 51% (42-60), 72% (65,78), 63% (57,68), respectively; GA-alone detected 55% (52% (46,63), 52% (44, 59) and 53% (47,53), respectively; whereas: HbA(1c)+GA detected: 69% (60,76), 82% (75,87) and 76% (71, 81). Therefore, for the total cohort detection of dysglycaemia HbA1c-alone vs HbA(1c)+GA detected 63% (57,68) vs 76% (71,81). Interpretation The opposite correlations of HbA1c and GA with BMI have now been demonstrated in an African based population. Improving detection of dysglycaemia by combining HbA1c and GA has important implications for diabetes risk screening. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] The ratio of glycated albumin to HbA1c as a haemoglobin glycation index with intra-familial correlations
    Amemiya, S.
    Mochizuki, M.
    Musha, I.
    Kikuchi, T.
    Yokomichi, H.
    Sugihara, S.
    Hoshino, T.
    DIABETOLOGIA, 2017, 60 : S509 - S510
  • [42] Glycated albumin and HbA1c as markers of lower extremity disease in US adults with and without diabetes
    Hicks, Caitlin W.
    Wang, Dan
    Matsushita, Kunihiro
    McEvoy, John W.
    Christenson, Robert
    Selvin, Elizabeth
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 184
  • [43] Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes
    Maruo, Saori
    Motoyama, Koka
    Hirota, Tomoe
    Kakutani, Yoshinori
    Yamazaki, Yuko
    Morioka, Tomoaki
    Mori, Katsuhito
    Fukumoto, Shinya
    Shioi, Atsushi
    Shoji, Tetsuo
    Inaba, Masaaki
    Emoto, Masanori
    DIABETOLOGY INTERNATIONAL, 2020, 11 (04) : 368 - 375
  • [44] Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes
    Saori Maruo
    Koka Motoyama
    Tomoe Hirota
    Yoshinori Kakutani
    Yuko Yamazaki
    Tomoaki Morioka
    Katsuhito Mori
    Shinya Fukumoto
    Atsushi Shioi
    Tetsuo Shoji
    Masaaki Inaba
    Masanori Emoto
    Diabetology International, 2020, 11 : 368 - 375
  • [45] Glycated Albumin and Fructosamine May Not Overcome Limitations of HbA1c in the Setting of Chronic Kidney Disease
    Jung, Molly
    Warren, Bethany
    Grams, Morgan
    Kwong, Diana
    Shafi, Tariq
    Coresh, Josef
    Rebholz, Casey
    Selvin, Elizabeth
    CIRCULATION, 2017, 135
  • [46] Is early measurement of glycated albumin and HbA1c useful for the prediction of treatment response in type 2 diabetes?
    Michaela Luconi
    Besmir Nreu
    Jinous Samavat
    Maria Lorubbio
    Agostino Ognibene
    Matteo Monami
    Edoardo Mannucci
    Acta Diabetologica, 2016, 53 : 669 - 672
  • [47] Investigation of Relationship Between Glycated Albumin, HbA1c, and their Ratio in Korean Patients with Impaired Glucose Metabolism
    Gu, Hyun Jung
    Cho, Sun Young
    Lee, Hee Joo
    Yang, Hyung-Seok
    Kim, Young Jin
    Park, Tae Sung
    CLINICAL LABORATORY, 2016, 62 (03) : 489 - 490
  • [48] Is early measurement of glycated albumin and HbA1c useful for the prediction of treatment response in type 2 diabetes?
    Luconi, Michaela
    Nreu, Besmir
    Samavat, Jinous
    Lorubbio, Maria
    Ognibene, Agostino
    Monami, Matteo
    Mannucci, Edoardo
    ACTA DIABETOLOGICA, 2016, 53 (04) : 669 - 672
  • [49] Dissociation of Glycated Albumin and HbA1c Is Associated With a Decline of Glomerular Filtration Rate as Evaluated by Inulin Clearance
    Tsuda, Akihiro
    Mori, Katsuhito
    Nakatani, Shinya
    Machiba, Yuri
    Uedono, Hideki
    Kurajoh, Masafumi
    Yamada, Shinsuke
    Morioka, Tomoaki
    Inaba, Masaaki
    Ishimura, Eiji
    Uchida, Junji
    Emoto, Masanori
    DIABETES CARE, 2021, 44 (11) : E188 - E189
  • [50] High glycated albumin (GA) levels and the GA/HbA1c ratio in patients with insulin autoimmune syndrome
    Koga M.
    Inada S.
    Taniguchi J.
    Nakatani Y.
    Yoshino H.
    Yoshino G.
    Okauchi Y.
    Mineo I.
    Diabetology International, 2017, 8 (2) : 199 - 204